Role of epigenetic and miR-22 and miR-29b alterations in the downregulation ofMat1aandMthfrgenes in early preneoplastic livers in rats induced by 2-acetylaminofluorene

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Bioinformatic and Genetic Association Analysis of MicroRNA Target Sites in One-Carbon Metabolism Genes

(2011) Nicole Stone et al.   PLoS One

Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma

(2010) Antal Csepregi et al.   BMC CANCER

Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry

(2010) María Berdasco et al.   DEVELOPMENTAL CELL

Molecular events in hepatic preneoplasia: A review

(2010) S.W. French   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Mammalian microRNAs predominantly act to decrease target mRNA levels

(2010) Huili Guo et al.   NATURE

MicroRNAs and pharmacogenomics

(2010) Noam Shomron   PHARMACOGENOMICS

Accumulation of driver and passenger mutations during tumor progression

(2010) I. Bozic et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies

(2010) James P Hamilton   Epigenomics

Aberrant DNA methylation in contrast with mutations

(2009) Toshikazu Ushijima et al.   CANCER SCIENCE

Genetic and Epigenetic Control of Molecular Alterations in Hepatocellular Carcinoma

(2009) Francesco Feo et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning

(2009) Rebecca A. Hinshelwood et al.   HUMAN MOLECULAR GENETICS

Global and gene-specific promoter methylation changes are related toanti-B[a]PDE-DNA adduct levels and influence micronuclei levels in polycyclic aromatic hydrocarbon-exposed individuals

(2009) Sofia Pavanello et al.   INTERNATIONAL JOURNAL OF CANCER

The N-terminus of histone H3 is required for de novo DNA methylation in chromatin

(2009) Jia-Lei Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation☆

(2009) Igor P. Pogribny et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Advances in Chemical Carcinogenesis: A Historical Review and Prospective

(2008) L. A. Loeb et al.   CANCER RESEARCH

Quantitative Analysis of DNA Methylation Profiles in Lung Cancer Identifies Aberrant DNA Methylation of Specific Genes and Its Association with Gender and Cancer Risk Factors

(2008) T. Vaissiere et al.   CANCER RESEARCH

Genetic and epigenetic changes in rat preneoplastic liver tissue induced by 2-acetylaminofluorene

(2008) Tetyana V. Bagnyukova et al.   CARCINOGENESIS

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

(2008) Yutaka Kondo et al.   NATURE GENETICS

Combinatorial patterns of histone acetylations and methylations in the human genome

(2008) Zhibin Wang et al.   NATURE GENETICS

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols

Adenovirus Small e1a Alters Global Patterns of Histone Modification

(2008) G. A. Horwitz et al.   SCIENCE

Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: Studies in rodents

(2007) Igor P. Pogribny et al.   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS